333 related articles for article (PubMed ID: 20493354)
41. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
42. Results of salvage treatment of the neck in patients with oral cancer.
Kowalski LP
Arch Otolaryngol Head Neck Surg; 2002 Jan; 128(1):58-62. PubMed ID: 11784256
[TBL] [Abstract][Full Text] [Related]
43. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
44. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
45. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
46. Isolated cervical recurrence of squamous cell carcinoma in the previously treated neck.
Krol BJ; Righi PD; Weisberger EC; Smith RM; Wynne M
Am J Otolaryngol; 2000; 21(6):360-5. PubMed ID: 11115520
[TBL] [Abstract][Full Text] [Related]
47. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
48. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
49. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
50. [Salvage surgery in squamous cell carcinoma of the oral cavity].
De Zinis LO; Ghizzardi D; Casati E; Nicolai P; Antonelli AR
Acta Otorhinolaryngol Ital; 2002 Jun; 22(3):135-41. PubMed ID: 12173283
[TBL] [Abstract][Full Text] [Related]
51. Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma.
Carvalho AL; Kowalski LP; Agra IM; Pontes E; Campos OD; Pellizzon AC
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):862-8. PubMed ID: 15944556
[TBL] [Abstract][Full Text] [Related]
52. The role of selective neck dissection in pathological N1 squamous cell carcinomas of the head and neck.
Yıldırım T; Ozmen OA; Erişen L; Kasapoğlu F; Coşkun H; Basut O; Onart S; Hızalan I
Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):63-9. PubMed ID: 21417967
[TBL] [Abstract][Full Text] [Related]
53. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas.
Taussky D; Dulguerov P; Allal AS
Head Neck; 2005 Mar; 27(3):182-6. PubMed ID: 15627262
[TBL] [Abstract][Full Text] [Related]
54. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
55. [Effect of salvage surgery for patients with recurrent oral squamous cell carcinoma].
Wang ZP; Chen WL; Pan CB; Li JS; Wang JG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):370-2. PubMed ID: 15498339
[TBL] [Abstract][Full Text] [Related]
56. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
57. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
58. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
59. Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for postsalvage survival.
Tan HK; Giger R; Auperin A; Bourhis J; Janot F; Temam S
Head Neck; 2010 Feb; 32(2):139-47. PubMed ID: 19536855
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]